申请人:Abeywardane Asitha
公开号:US20110275800A1
公开(公告)日:2011-11-10
This invention relates to a compound of formula (I) and the pharmaceutically acceptable salts thereof wherein R
1
, R
2
, R
4
. Ar and Het are as defined herein. The invention also relates to methods of using the compound of formula (I) to treat a diseases and disorders that are mediated or sustained through the activity of CCR
10
.
本发明涉及公式(I)的化合物及其药学上可接受的盐,其中R1、R2、R4、Ar和Het的定义如本文所述。本发明还涉及使用公式(I)的化合物治疗通过CCR10活性介导或持续的疾病和障碍的方法。